Hexal AG Sustainability Profile
Hexal AG, a prominent player in the pharmaceutical industry, is headquartered in Holzkirchen, Germany. Founded in 1986, the company has established itself as a leader in the development and production of generic medicines, catering to a diverse range of therapeutic areas. With a strong presence across Europe, Hexal AG is renowned for its commitment to quality and innovation, offering a comprehensive portfolio of high-quality generics that are both affordable and effective. The company’s core products include a wide array of prescription medications, which are distinguished by their rigorous quality standards and adherence to regulatory requirements. Hexal AG has achieved significant milestones, including numerous product launches and strategic partnerships, solidifying its market position as a trusted provider in the pharmaceutical sector. With a focus on patient-centric solutions, Hexal AG continues to contribute to improved healthcare outcomes across its operational regions.
DitchCarbon Score
How does Hexal AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hexal AG's score of 94 is higher than 96% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Hexal AG, headquartered in Germany, currently does not report specific carbon emissions data for the most recent year, as no absolute emissions figures are available. However, the company is part of a corporate family relationship with Novartis AG, from which it inherits emissions data and climate commitments. As a current subsidiary of Novartis AG, Hexal AG aligns with the sustainability initiatives and climate targets set by its parent company. Novartis has committed to significant climate action, including targets set through the Science Based Targets initiative (SBTi), and participates in various sustainability frameworks such as CDP, RE100, and the Climate Pledge. These initiatives aim to reduce greenhouse gas emissions across all scopes, including Scope 1, 2, and 3 emissions. While specific reduction targets for Hexal AG are not detailed, the overarching commitments from Novartis AG indicate a strong focus on sustainability and emissions reduction. Hexal AG's climate strategy is thus influenced by Novartis's industry-leading practices and goals, reflecting a commitment to addressing climate change within the pharmaceutical sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 75,620,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 158,430,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Hexal AG's Industry?
How Carbon Intensive is Hexal AG's Location?
Hexal AG's Scope 3 Categories Breakdown
Hexal AG's Scope 3 emissions, which decreased by 15% last year and decreased by approximately 15% since 2023, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 69% of Scope 3 emissions.
Top Scope 3 Categories
Hexal AG's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Hexal AG has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
